Twelve years ago, Christian Angermayer took a mushroom trip that inspired him to try to create FDA-approved medicines from psychedelic drugs. Now Big Pharma is making a $2.8 billion bet on his vision.
On Easter Sunday in 2014, Christian Angermayer, the German investor, was on the beach on the Caribbean island of Canouan with three friends, contemplating whether he should take magic mushrooms.
Before he made his decision, he called a professor he k... [8722 chars]